This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Ondexxya
  • /
  • A Study in Older Subject to Evaluate the Safety an...
Clinical trial

A Study in Older Subject to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Rivaroxaban

Read time: 2 mins
Last updated:1st May 2014
Identifier: NCT02220725
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest